Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 35

Trial Status

Completed2
Recruiting1
Terminated1
Other2

Role Distribution

Principal Investigator4
Other Roles2
PI Rate67%

Activity Timeline

Clinical Trials (6)

NCT04214990Phase 3Recruiting
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
AspirinGastric Cancer
StudydirectorStart date: 2020-02-15
NCT02557932Phase 3Completed
Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication
Family History of Stomach CancerHelicobacter Pylori Infection
PrincipalinvestigatorStart date: 2015-09-01
NCT02112214Phase 3Active Not Recruiting
Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Gastric CancerHelicobacter Pylori Infection
StudydirectorStart date: 2014-06-01
NCT01678027Phase 3Active Not Recruiting
Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication
Family MembersGastric CancerHelicobacter Pylori Infection
Principalinvestigator
NCT02150447Phase 3Terminated
The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
BleedingGastric Cancer
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Moo In Park, M.D., Ph.D.

Kosin University Gospel Hospital

Related
1 trials

Shared therapeutic areas:

HemorrhageCancer of Stomach

Worked with same sponsors:

Gyeongsang National University HospitalKosin University Gospel Hospital+2 more
Collaborated on 1 trial
Similarity Score24%

Won Sup Lee, M.D., Ph.D.

Gyeongsang National University Hospital

Related
1 trials

Shared therapeutic areas:

HemorrhageCancer of Stomach

Worked with same sponsors:

Gyeongsang National University HospitalKosin University Gospel Hospital+2 more
Collaborated on 1 trial
Similarity Score24%

Rolando Herrero, M.D.,Ph.D

International Agency for Research on Cancer

Related
1 trials

Shared therapeutic areas:

Cancer of StomachHelicobacter Pylori Infection

Worked with same sponsors:

Chonnam National University HospitalChuncheon Sacred Heart Hospital+10 more
Collaborated on 1 trial
Similarity Score24%

Gwang Ha Kim, M.D., Ph.D.

Pusan National University Hospital

Related
1 trials

Shared therapeutic areas:

HemorrhageCancer of Stomach

Worked with same sponsors:

Gyeongsang National University HospitalKosin University Gospel Hospital+2 more
Collaborated on 1 trial
Similarity Score24%

Xiuli Zuo, MD,PhD

Qilu Hospital of Shandong University

Related
26 trials

Shared therapeutic areas:

Helicobacter Pylori InfectionCancer of Stomach
Similarity Score10%

Heinz-Josef Lenz, MD

University of Southern California

Related
13 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score5%

Anissa MEGZARI

Centre Hospitalier Universitaire de Nīmes

Related
29 trials

Shared therapeutic areas:

Hemorrhage
Similarity Score5%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score5%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

Related
14 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score5%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT04214990Phase 3StudyDirector

Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients

AspirinGastric Cancer
Recruiting
NCT02557932Phase 3PrincipalInvestigator

Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori Eradication

Family History of Stomach CancerHelicobacter Pylori Infection
Completed
NCT02112214Phase 3StudyDirector

Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population

Gastric CancerHelicobacter Pylori Infection
Active Not Recruiting
NCT01002443Phase 2PrincipalInvestigator

Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

Gastric Cancer
Completed
NCT01678027Phase 3PrincipalInvestigator

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

Family MembersGastric CancerHelicobacter Pylori Infection
Active Not Recruiting
NCT02150447Phase 3PrincipalInvestigator

The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding

BleedingGastric Cancer
Terminated

All 6 trials loaded